RORC and leukemia: To confirm the inhibitory effect of XY018 in t(4;11) leukemia, we measured the expression of RORγ in the CRISPR/Cas9 t(4;11) cells upon increasing concentrations of XY018 with intracellular flow cytometry and found an analogous dose-dependent decrease of the target protein (Fig. 4A).